138 related articles for article (PubMed ID: 29094784)
1. Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7).
Brédart A; Anota A; Young T; Tomaszewski KA; Arraras JI; Moura De Albuquerque Melo H; Schmidt H; Friend E; Bergenmar M; Costantini A; Vassiliou V; Hureaux J; Marchal F; Tomaszewska IM; Chie WC; Ramage J; Beaudeau A; Conroy T; Bleiker E; Kulis D; Bonnetain F; Aaronson NK;
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 29094784
[TBL] [Abstract][Full Text] [Related]
2. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
[TBL] [Abstract][Full Text] [Related]
3. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
4. Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.
Oberguggenberger AS; Nagele E; Inwald EC; Tomaszewski K; Lanceley A; Nordin A; Creutzberg CL; Kuljanic K; Kardamakis D; Schmalz C; Arraras J; Costantini A; Almont T; Wei-Chu C; Dehandschutter S; Winters Z; Greimel E;
Cancer Med; 2018 Mar; 7(3):635-645. PubMed ID: 29436144
[TBL] [Abstract][Full Text] [Related]
5. EORTC QLQ-COMU26: a questionnaire for the assessment of communication between patients and professionals. Phase III of the module development in ten countries.
Arraras JI; Wintner LM; Sztankay M; Tomaszewski KA; Hofmeister D; Costantini A; Bredart A; Young T; Kuljanic K; Tomaszewska IM; Kontogianni M; Chie WC; Kulis D; Greimel E;
Support Care Cancer; 2017 May; 25(5):1485-1494. PubMed ID: 28025709
[TBL] [Abstract][Full Text] [Related]
6. Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction.
Winters ZE; Balta V; Thomson HJ; Brandberg Y; Oberguggenberger A; Sinove Y; Unukovych D; Nava M; Sandelin K; Johansson H; ; Dobbeleir J; Blondeel P; Bruno N; Catanuto G; Llewellyn-Bennett R
Br J Surg; 2014 Mar; 101(4):371-82. PubMed ID: 24474151
[TBL] [Abstract][Full Text] [Related]
7. The EORTC cancer outpatient satisfaction with care questionnaire in ambulatory radiotherapy: EORTC OUT-PATSAT35 RT. Validation study for Spanish patients.
Arraras JI; Rico M; Vila M; Chicata V; Asin G; Martinez M; Hernandez B; Arias F; Martinez E
Psychooncology; 2010 Jun; 19(6):657-64. PubMed ID: 19771588
[TBL] [Abstract][Full Text] [Related]
8. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
Winstanley JB; Young TE; Boyle FM; Bergenmar M; Bottomley A; Burmeister B; Campana LG; Garioch JJ; King M; Nikolic DV; van de Poll-Franse LV; Saw R; Thompson JF; White EG;
Melanoma Res; 2015 Feb; 25(1):47-58. PubMed ID: 25325247
[TBL] [Abstract][Full Text] [Related]
9. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.
Bjelic-Radisic V; Cardoso F; Cameron D; Brain E; Kuljanic K; da Costa RA; Conroy T; Inwald EC; Serpentini S; Pinto M; Weis J; Morag O; Lindviksmoen Astrup G; Tomaszweksi KA; Pogoda K; Sinai P; Sprangers M; Aaronson N; Velikova G; Greimel E; Arraras J; Bottomley A;
Ann Oncol; 2020 Feb; 31(2):283-288. PubMed ID: 31959345
[TBL] [Abstract][Full Text] [Related]
10. The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development.
Gamper EM; Groenvold M; Petersen MA; Young T; Costantini A; Aaronson N; Giesinger JM; Meraner V; Kemmler G; Holzner B;
Psychooncology; 2014 Apr; 23(4):397-403. PubMed ID: 24217943
[TBL] [Abstract][Full Text] [Related]
11. Cross-cultural development of the EORTC QLQ-SWB36: a stand-alone measure of spiritual wellbeing for palliative care patients with cancer.
Vivat B; Young T; Efficace F; Sigurđadóttir V; Arraras JI; Åsgeirsdóttir GH; Brédart A; Costantini A; Kobayashi K; Singer S;
Palliat Med; 2013 May; 27(5):457-69. PubMed ID: 22843128
[TBL] [Abstract][Full Text] [Related]
12. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
[TBL] [Abstract][Full Text] [Related]
13. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
Holzner B; Efficace F; Basso U; Johnson CD; Aaronson NK; Arraras JI; Smith AB; Chow E; Oberguggenberger AS; Bottomley A; Steiner H; Incrocci L; Giesinger JM
Qual Life Res; 2013 Mar; 22(2):369-78. PubMed ID: 22407356
[TBL] [Abstract][Full Text] [Related]
14. The early development phases of a European Organisation for Research and Treatment of Cancer (EORTC) module to assess patient reported outcomes (PROs) in women undergoing breast reconstruction.
Thomson HJ; Winters ZE; Brandberg Y; Didier F; Blazeby JM; Mills J
Eur J Cancer; 2013 Mar; 49(5):1018-26. PubMed ID: 23063353
[TBL] [Abstract][Full Text] [Related]
15. Psychometric evaluation of the European Organization for Research and Treatment of Cancer in-patient satisfaction with care questionnaire ('Sinhala' version) for use in a South-Asian setting.
Jayasekara H; Rajapaksa L; Bredart A
Int J Qual Health Care; 2008 Jun; 20(3):221-6. PubMed ID: 18339668
[TBL] [Abstract][Full Text] [Related]
16. Quality of care in the oncology outpatient setting from patients' perspective: a systematic review of questionnaires' content and psychometric performance.
Brédart A; Kop JL; Efficace F; Beaudeau A; Brito T; Dolbeault S; Aaronson N;
Psychooncology; 2015 Apr; 24(4):382-94. PubMed ID: 25196048
[TBL] [Abstract][Full Text] [Related]
17. [Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment].
Poinsot R; Altmeyer A; Conroy T; Savignoni A; Asselain B; Léonard I; Marx E; Cosquer M; Sévellec M; Gledhill J; Rodary C; Mercier M; Dickès P; Fabbro M; Antoine P; Guerif S; Schraub S; Dolbeault S; Brédart A
Bull Cancer; 2006 Mar; 93(3):315-27. PubMed ID: 16567319
[TBL] [Abstract][Full Text] [Related]
18. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
Weis J; Arraras JI; Conroy T; Efficace F; Fleissner C; Görög A; Hammerlid E; Holzner B; Jones L; Lanceley A; Singer S; Wirtz M; Flechtner H; Bottomley A
Psychooncology; 2013 May; 22(5):1002-7. PubMed ID: 22565359
[TBL] [Abstract][Full Text] [Related]
19. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
[TBL] [Abstract][Full Text] [Related]
20. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).
Kimman ML; Rotteveel AH; Wijsenbeek M; Mostard R; Tak NC; van Jaarsveld X; Storm M; Wijnsma KL; Gelens M; van de Kar NCAJ; Wetzels J; Dirksen CD
Patient; 2017 Oct; 10(5):629-642. PubMed ID: 28357591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
